| 1 |
Ba X, Wang H, Huang Y, Yan J, Han L, Lin W, Shen P, Huang Y, Yang S, Qin K, Tu S, Chen Z. Simiao pill attenuates collagen-induced arthritis and bleomycin-induced pulmonary fibrosis in mice by suppressing the JAK2/STAT3 and TGF-β/Smad2/3 signalling pathway. J Ethnopharmacol 2023;309:116274. [PMID: 36841380 DOI: 10.1016/j.jep.2023.116274] [Reference Citation Analysis]
|
| 2 |
Ren J, Ding Y, Zhao J, Sun Y. Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on clinical and radiological features and prognosis. Rheumatol Int 2023;43:293-301. [PMID: 36166058 DOI: 10.1007/s00296-022-05219-9] [Reference Citation Analysis]
|
| 3 |
Rawat S, Dhaundhiyal K, Dhramshaktu IS, Tazneem B, Salfi R, Chellappan DK, Dureja H, Singh SK, Dua K, Gupta G. Introduction to Lung Disease. Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases 2023. [DOI: 10.1007/978-981-19-7656-8_1] [Reference Citation Analysis]
|
| 4 |
Salem HF, Abd El-Maboud MM, Said ASA, Salem MN, Sabry D, Hussain N, El-Ghafar OAMA, Hussein RRS. Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals (Basel) 2022;16. [PMID: 36678557 DOI: 10.3390/ph16010060] [Reference Citation Analysis]
|
| 5 |
Nasonov EL, Ananyeva LP, Avdeev SN. Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology. Naučno-praktičeskaâ revmatologiâ 2022;60:517-534. [DOI: 10.47360/1995-4484-2022-1] [Reference Citation Analysis]
|
| 6 |
Koulouri V, Bakasis AD, Marketos N, Tavernaraki K, Giannelou M, Moutsopoulos HM, Mavragani CP. Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations. J Transl Autoimmun 2023;6:100183. [PMID: 36619654 DOI: 10.1016/j.jtauto.2022.100183] [Reference Citation Analysis]
|
| 7 |
Schäfer C, Keyßer G. Lifestyle Factors and Their Influence on Rheumatoid Arthritis: A Narrative Review. J Clin Med 2022;11. [PMID: 36498754 DOI: 10.3390/jcm11237179] [Reference Citation Analysis]
|
| 8 |
Wang X, Zhou D, Zhou W, Liu J, Xue Q, Huang Y, Cheng C, Wang Y, Chang J, Wang P, Miao C. Clematichinenoside AR inhibits the pathology of rheumatoid arthritis by blocking the circPTN/miR-145-5p/FZD4 signal axis. International Immunopharmacology 2022;113:109376. [DOI: 10.1016/j.intimp.2022.109376] [Reference Citation Analysis]
|
| 9 |
Denis A, Henket M, Ernst M, Maes N, Thys M, Regnier C, Malaise O, Frix A, Gester F, Desir C, Meunier P, Louis R, Malaise M, Guiot J. Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1024298] [Reference Citation Analysis]
|
| 10 |
Enomoto N, Naoi H, Mochizuka Y, Isayama T, Tanaka Y, Fukada A, Aono Y, Katsumata M, Yasui H, Mori K, Karayama M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases. BMC Pulm Med 2022;22:387. [PMID: 36289542 DOI: 10.1186/s12890-022-02197-3] [Reference Citation Analysis]
|
| 11 |
Temmoku J, Miyata M, Suzuki E, Sumichika Y, Saito K, Yoshida S, Matsumoto H, Fujita Y, Matsuoka N, Asano T, Sato S, Watanabe H, Migita K. Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis. PLoS ONE 2022;17:e0274775. [DOI: 10.1371/journal.pone.0274775] [Reference Citation Analysis]
|
| 12 |
Shaaban HH, Hozayen WG, Khaliefa AK, El-kenawy AE, Ali TM, Ahmed OM. Diosmin and Trolox Have Anti-Arthritic, Anti-Inflammatory and Antioxidant Potencies in Complete Freund’s Adjuvant-Induced Arthritic Male Wistar Rats: Roles of NF-κB, iNOS, Nrf2 and MMPs. Antioxidants 2022;11:1721. [DOI: 10.3390/antiox11091721] [Reference Citation Analysis]
|
| 13 |
Mou X, Jin Y, Jin D, Guan J, Zhang Q. Serum HDAC4 level in rheumatoid arthritis: Longitudinal change during treatment and correlation with clinical outcomes. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24594] [Reference Citation Analysis]
|
| 14 |
Yamakawa H, Toyoda Y, Baba T, Kishaba T, Fukuda T, Takemura T, Kuwano K. Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review. JCM 2022;11:3835. [DOI: 10.3390/jcm11133835] [Reference Citation Analysis]
|
| 15 |
Nasonov EL, Avdeeva AS. Interleukin 18 in Immune-mediated rheumatic diseases and COVID-19. Naučno-praktičeskaâ revmatologiâ 2022;60:195-204. [DOI: 10.47360/1995-4484-2022-195-204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Lillehoj EP, Luzina IG, Atamas SP. Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond. Front Immunol 2022;13:883079. [PMID: 35479093 DOI: 10.3389/fimmu.2022.883079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
